A standard dose of RhoGAM provides roughly 12 weeks of protection against Rh sensitization. The injection has a half-life of about 31 days, meaning half the protective antibodies are cleared from your body in roughly one month. This is why the routine prenatal dose is timed at 28 weeks of gestation: it covers you through the remainder of pregnancy until delivery, when a second dose is given if needed.
How RhoGAM Works in Your Body
RhoGAM is a concentrated dose of anti-Rh antibodies. If you’re Rh-negative and your baby is Rh-positive, small amounts of the baby’s blood can cross into your bloodstream during pregnancy or delivery. Without intervention, your immune system would recognize those Rh-positive blood cells as foreign and build its own permanent antibodies against them. That process, called sensitization, isn’t dangerous for a first pregnancy but can cause serious problems in future pregnancies, where your immune system would attack an Rh-positive baby’s red blood cells.
RhoGAM works by essentially intercepting those fetal red blood cells before your immune system notices them. The injected antibodies coat the Rh-positive cells and mark them for removal, preventing your body from ever mounting its own immune response. Because these are borrowed antibodies rather than ones your body produced, they gradually fade. That fading is what determines how long the shot “lasts.”
The 12-Week Protection Window
With a half-life of approximately 31 days, the antibodies from a single RhoGAM dose decline steadily over several weeks. Enough protective antibody remains in circulation for about 12 weeks to neutralize small amounts of fetal blood that might enter your system. After that point, levels drop low enough that protection becomes unreliable.
This 12-week window is the reason for the standard dosing schedule. A shot at 28 weeks covers you through roughly 40 weeks, the typical end of pregnancy. If you deliver within that window, the prenatal dose has you covered. A postpartum dose is then given within 72 hours of delivery to address any larger transfer of fetal blood that occurs during birth itself.
When You Might Need It Earlier or More Often
The 28-week dose isn’t always the first one you’ll receive. Any event that could cause fetal blood to mix with yours may call for RhoGAM earlier in pregnancy. Common triggers include vaginal bleeding, miscarriage, ectopic pregnancy, amniocentesis, and abdominal trauma. For events before 12 weeks of gestation, a smaller 50-microgram dose is typically used. After 12 weeks, the full 300-microgram dose is standard.
If you received a dose early in pregnancy for one of these reasons, the 12-week clock starts from that injection. You would still need the routine 28-week dose on schedule, because the earlier shot will have worn off by then. Each dose is independent, protecting you for its own roughly 12-week span.
The Routine Dosing Schedule
For an uncomplicated pregnancy, most Rh-negative women receive two doses total. The first is given around 28 weeks of gestation. The second is given within 72 hours after delivery, but only if the baby tests Rh-positive. If the baby turns out to be Rh-negative, the postpartum dose is unnecessary because there was never a mismatch to worry about.
Newer cell-free DNA testing can now determine a baby’s Rh status from a maternal blood draw during pregnancy. The American College of Obstetricians and Gynecologists has noted that if this testing confirms the fetus is Rh-negative, the 28-week antepartum dose may not be needed. This has become particularly relevant during periodic supply shortages, when ACOG has recommended prioritizing the postpartum dose over the prenatal one if supplies are limited.
Why the Postpartum Dose Matters Most
Delivery is when the largest volume of fetal blood typically enters your circulation. The prenatal dose at 28 weeks handles the small, gradual mixing that can happen during the third trimester, but birth itself, whether vaginal or cesarean, involves a much more significant exchange. That’s why the postpartum dose is considered the highest priority even in shortage situations.
The 72-hour window after delivery is the target for this dose. The sooner it’s given, the more effectively it intercepts fetal cells before your immune system can respond. Once sensitization occurs, it’s permanent and cannot be reversed by later RhoGAM doses.
What It Means for Future Pregnancies
RhoGAM does not provide lasting immunity. Every Rh-incompatible pregnancy requires its own course of injections. The antibodies from a previous pregnancy’s doses are long gone within a few months of delivery. If you become pregnant again with an Rh-positive baby, you’ll follow the same schedule: a dose around 28 weeks and another after delivery.
Because the injected antibodies are temporary, they can show up on blood tests for several weeks after your shot. If you have an antibody screen (indirect Coombs test) done shortly after receiving RhoGAM, it may come back positive. This is expected and simply reflects the injected antibodies still circulating, not true sensitization. Your healthcare team will account for the timing of your last dose when interpreting these results.